Valneva Stock: Nearly +10% in One Week!
Valneva laboratory regains momentum in the late afternoon, in a rising Parisian market. The stock erases some of its recent slide, after weeks marked by a capital increase and deteriorated quarterly results. Today's rebound brings the biotech back above a technical threshold.
The stock crosses back above its MM20 at €2.46 and marks one of the strongest gains in the SBF 120
Valneva's stock is up 4.04% at €2.68, among the strongest increases in the SBF 120, while the broader index is up 0.77% in session. This movement brings the weekly gain to 9.57%, after a quarter marked by a decline of nearly 43%. The stock has moved back above its 20-day moving average (€2.46), with a gap of nearly 9%. However, it remains below the MM50 at €2.81 and significantly under the MM200 at €3.82, indicating that the medium-term trend has not reversed. The RSI at 47 indicates a neutral configuration, without excessive selling or buying pressure. The resistance at €2.74, close to the current price, is now the next level to watch.
The day's rebound comes in the context of digesting recent announcements
Today's rebound occurs in the context of digesting recent announcements. The first quarter 2026 accounts, published on May 13, showed a 37% decline in revenue and a net loss of 32.1 million euros, compared to 9.2 million a year earlier. On this occasion, the company announced a reorganization plan aimed at reducing its operational costs by 25 to 35% and its global workforce by 10 to 15%. The 2026 revenue guidance was adjusted to a range of 135 to 150 million euros, with a focus on key strategic projects. Earlier, at the end of April, Valneva had completed a reserved offer of 84 million euros, the dilutive effect of which weighed on the stock price in the weeks that followed. Next appointment: the general meeting on June 1, 2026.
